These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33336742)

  • 1. MicroRNA-198 inhibits metastasis of thyroid cancer by targeting H3F3A.
    Fang J; Zhu JM; Dai HL; He LM; Kong L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12232-12240. PubMed ID: 33336742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
    Wei YY; Ren TL
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
    Wang GF; Wen LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
    Chen AY; Zhang K; Liu GQ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
    Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
    Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
    Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
    He Y; Wu L; Dai Y; Li J; Liu S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
    Shi XY; Lin JJ; Ge XJ; Shi Y
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
    Que LM; Yang XR; Zhang YC; Zhong H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
    Li Y; Zhou HC; Zhang Y; Huang H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29c-3p inhibits osteosarcoma cell proliferation through targeting PIK3R3.
    Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2239-2247. PubMed ID: 32196574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
    Pan DS; Cao P; Li JJ; Fan D; Song ZQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4254-4263. PubMed ID: 31173297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.